FDA Inspection 1314716 — Boehringer Laboratories, Inc.

Boehringer Laboratories, Inc. — FEI 2518417

The FDA completed an inspection of Boehringer Laboratories, Inc. on Jun 24, 2026 in Phoenixville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 24, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Phoenixville, PA (United States)

Citations

IDCFRDescription
23136ISO 13485:2016 Clause 7.3.10Design and development files not maintained
23169ISO 13485:2016 Clause 7.5.6Procedures for validation of processes not documented

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.